Ventyx Biosciences Inc
(VTYX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,791 | 68,986 | 0 | 0 | N/A |
| Marketable Securities | 187,785 | 72,966 | 0 | 0 | N/A |
| TOTAL | $263,020 | $145,659 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 254 | 219 | N/A | N/A | N/A |
| Investments And Advances | 28,148 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 60 | 2,831 | 0 | 0 | 0 |
| TOTAL | $28,462 | $3,050 | $N/A | $N/A | $N/A |
| Total Assets | $291,482 | $148,709 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,661 | 4,263 | 0 | 0 | 0 |
| Accrued Expenses | 7,622 | 7,546 | 0 | 0 | N/A |
| TOTAL | $12,283 | $11,809 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 224,521 | 0 | 0 | 0 |
| TOTAL | $N/A | $224,521 | $N/A | $N/A | $N/A |
| Total Liabilities | $12,283 | $236,330 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,730 | 50,297 | N/A | N/A | N/A |
| Common Shares | 5 | 0 | 0 | 0 | N/A |
| Retained earnings | -117,799 | -100,031 | 0 | 0 | N/A |
| Other shareholders' equity | -58 | 17 | 0 | 0 | 0 |
| TOTAL | $279,199 | $-87,621 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $291,482 | $148,709 | $0 | $0 | $0 |